查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1977684

全球甲狀腺功能檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Thyroid Function Test Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計甲狀腺功能檢測市場將從 2025 年的 25.8 億美元成長到 2034 年的 42.3 億美元，2026 年至 2034 年的複合年成長率為 5.66%。

全球甲狀腺功能檢測市場正穩定成長，主要受甲狀腺疾病（如甲狀腺機能低下症和甲狀腺功能亢進）盛行率上升的推動。人們對早期診斷和定期體檢的日益重視，也促進了對甲狀腺篩檢的需求。診斷技術的進步，包括自動化免疫檢測系統和高靈敏度檢測套組，提高了檢測的準確性和效率。發展中地區醫療基礎設施的擴張也進一步推動了市場成長。

成長要素包括老年人口的增加和文明病發生率的上升。預防醫學的廣泛應用以及高風險族群定期監測的普及，進一步增強了市場需求。醫院和診斷檢查室正在投資先進的檢測平台，以加快檢測結果的出具。此外，已開發國家優惠的報銷政策也促進了甲狀腺功能檢測的廣泛應用。

展望未來，就地檢驗的創新和檢測系統的數位化整合預計將對市場產生積極影響。新興經濟體診斷服務可近性的提高將創造新的成長機會。各公司正致力於開發經濟高效且高靈敏度的檢測方法。隨著全球對內分泌疾病的認知不斷提高以及早期診斷的普及，全球甲狀腺功能檢測市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球甲狀腺功能檢測市場：按類型分類

  • 市場分析、洞察與預測
  • TSH 偵測
  • T4 檢測
  • T3檢查
  • 其他

第5章：全球甲狀腺功能檢測市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院檢查室
  • 診斷檢查室
  • 研究機構
  • 其他

第6章 全球甲狀腺功能檢測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • DiaSorin SPA
    • Danaher Corporation
    • Siemens Healthineers
    • Merck KGaA
    • BioMAfA（C）Rieux SA
    • Qualigen Inc
    • Autobio Diagnostics Co. Ltd
簡介目錄
Product Code: VMR112112683

The Thyroid Function Test Market size is expected to reach USD 4.23 Billion in 2034 from USD 2.58 Billion (2025) growing at a CAGR of 5.66% during 2026-2034.

The Global Thyroid Function Test Market is witnessing steady growth driven by the rising prevalence of thyroid disorders such as hypothyroidism and hyperthyroidism. Increasing awareness about early diagnosis and routine health check-ups is boosting demand for thyroid screening tests. Advancements in diagnostic technologies, including automated immunoassay analyzers and high-sensitivity testing kits, are improving accuracy and efficiency. Expanding healthcare infrastructure in developing regions is further supporting market expansion.

Key growth drivers include the growing geriatric population and rising incidence of lifestyle-related disorders. Increased adoption of preventive healthcare practices and regular monitoring among high-risk groups are strengthening demand. Hospitals and diagnostic laboratories are investing in advanced testing platforms to enhance turnaround times. Additionally, favorable reimbursement policies in developed economies are encouraging wider adoption of thyroid function tests.

Looking ahead, the market is expected to benefit from point-of-care testing innovations and digital integration of laboratory systems. Emerging economies improving access to diagnostic services will create new growth opportunities. Companies are focusing on developing cost-effective and highly sensitive assays. As awareness and early diagnosis of endocrine disorders increase globally, the Global Thyroid Function Test Market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • TSH Test
  • T4 Test
  • T3 Test
  • Others

By End-user

  • Hospital-based Laboratories
  • Diagnostic Laboratories
  • Research Institutes
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Abbott Laboratories, DiaSorin SpA, Danaher Corporation, Siemens Healthineers, Merck KGaA, bioMrieux SA, Qualigen Inc, Autobio Diagnostics Co Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL THYROID FUNCTION TEST MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. TSH Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. T4 Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. T3 Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THYROID FUNCTION TEST MARKET: BY END-USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-user
  • 5.2. Hospital-based Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THYROID FUNCTION TEST MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End-user
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End-user
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End-user
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End-user
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End-user
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL THYROID FUNCTION TEST INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Thermo Fisher Scientific Inc
    • 8.2.2 F. Hoffmann-La Roche Ltd
    • 8.2.3 Abbott Laboratories
    • 8.2.4 DiaSorin S.P.A
    • 8.2.5 Danaher Corporation
    • 8.2.6 Siemens Healthineers
    • 8.2.7 Merck KGaA
    • 8.2.8 BioMAfA(C)Rieux SA
    • 8.2.9 Qualigen Inc
    • 8.2.10 Autobio Diagnostics Co. Ltd